Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?

Allergic bronchopulmonary aspergillosis (ABPA) is a severe hypersensitivity reaction to aspergillus species colonizing the airways of patients with asthma or cystic fibrosis. Biologics including anti-IgE and a...

Source: Allergy, Asthma and Clinical Immunology - June 26, 2020 Category: Allergy & Immunology Authors: Carlo M ümmler, Bernd Kemmerich, Jürgen Behr, Nikolaus Kneidinger and Katrin Milger Tags: Case report Source Type: research